Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Waters

Showing results (711-720 of 1,025) with videos related to

Pageof 103
Sort By:
Medical and Pediatric Oncology|January 1, 1980
A randomized study of intermittent chemotherapy with or without BCG inoculation in maintenance therapy of childhood ALLH Ekert, K D Waters, R N Matthews, et al.
Metabolism: Clinical and Experimental|November 20, 2018
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)Kwok Leung Ong, Nicholas Hui, Andrzej S Januszewski, et al.
Applied Optics|November 13, 2015
InAlAs/InGaAs avalanche photodiode arrays for free space optical communicationMike S Ferraro, William R Clark, William S Rabinovich, et al.
Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
American Heart Journal|February 23, 2020
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapibJean-Claude Tardif, Marie-Pierre Dubé, Marc A Pfeffer, et al.
Journal of the American Chemical Society|July 24, 2025
Stimulated Emission from Below the Bandgap in Giant Quantum ShellsAmelia D Waters, Mykhailo V Bondarchuk, Christopher M Hicks, et al.
Pathology|April 1, 1981
The Rye classification of a population based series of Hodgkin's disease patients in Western AustraliaL R Matz, L R Finlay-Jones, E D Waters, et al.
Transplantation Proceedings|November 20, 1997
Expanded liver donor age over 60 years for hepatic transplantationT Karatzas, L Olson, G Ciancio, et al.
The New England Journal of Medicine|August 24, 2000
Effects of estrogen replacement on the progression of coronary-artery atherosclerosisD M Herrington, D M Reboussin, K B Brosnihan, et al.
Pageof 103

Showing results (711-720 of 1,025) with videos related to

Sort By:
Pageof 103
Medical and Pediatric Oncology|January 1, 1980
A randomized study of intermittent chemotherapy with or without BCG inoculation in maintenance therapy of childhood ALLH Ekert, K D Waters, R N Matthews, et al.
Metabolism: Clinical and Experimental|November 20, 2018
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)Kwok Leung Ong, Nicholas Hui, Andrzej S Januszewski, et al.
Applied Optics|November 13, 2015
InAlAs/InGaAs avalanche photodiode arrays for free space optical communicationMike S Ferraro, William R Clark, William S Rabinovich, et al.
Circulation. Cardiovascular Genetics|December 3, 2011
The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studiesBenoit J Arsenault, S Matthijs Boekholdt, G Kees Hovingh, et al.
Clinical Cardiology|September 16, 1999
Management strategies in unstable coronary artery disease--current problems and future directions. The UCAD CouncilF W Verheugt, R C Becker, M E Bertrand, et al.
American Heart Journal|February 23, 2020
Study design of Dal-GenE, a pharmacogenetic trial targeting reduction of cardiovascular events with dalcetrapibJean-Claude Tardif, Marie-Pierre Dubé, Marc A Pfeffer, et al.
Journal of the American Chemical Society|July 24, 2025
Stimulated Emission from Below the Bandgap in Giant Quantum ShellsAmelia D Waters, Mykhailo V Bondarchuk, Christopher M Hicks, et al.
Pathology|April 1, 1981
The Rye classification of a population based series of Hodgkin's disease patients in Western AustraliaL R Matz, L R Finlay-Jones, E D Waters, et al.
Transplantation Proceedings|November 20, 1997
Expanded liver donor age over 60 years for hepatic transplantationT Karatzas, L Olson, G Ciancio, et al.
The New England Journal of Medicine|August 24, 2000
Effects of estrogen replacement on the progression of coronary-artery atherosclerosisD M Herrington, D M Reboussin, K B Brosnihan, et al.
Pageof 103